Patent · US Active

Compounds and methods for treating cancer

US8501906B2 · kind B2 · utility

2Cited by
6References
8Claims
0Family size

Assignee

Inventor

Key dates

Filing dateJun 29, 2010
Grant dateAug 6, 2013
Priority date
Expiry dateJan 5, 2031

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K14/65
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides a method of treating cancer involving administering an insulin-like growth factor-1 receptor (IGF-1 receptor) agonist and an anti-cancer chemotherapeutic agent. Also provided are compounds for treating cancer comprising an IGF-1-receptor ligand coupled to an anti-cancer chemotherapeutic agent. Also provided are compounds for treating cancer comprising an insulin-receptor ligand coupled to an anti-cancer chemotherapeutic agent.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.